Evolus Inc., a performance beauty company, announced the approval of non-qualified stock options and restricted stock units (RSUs) for 16 newly hired non-executive employees under its 2023 Inducement Incentive Plan. The compensation package includes stock options to purchase 12,706 shares at an exercise price of $9.98 per share, reflecting the closing price on the grant date of May 12, 2025. These options have a 10-year term and will vest over four years, with 25% vesting annually. Additionally, 40,576 RSUs were granted, also vesting at 25% annually starting from May 7, 2025. These awards are contingent upon continuous employment with Evolus.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。